THE INGREDIENTS FOR COGNITIVE CHANGE
Axona® is a prescription medical food intended for the clinical dietary management of the metabolic processes associated with mild to moderate Alzheimer’s disease.
Address glucose hypometabolism
Axona addresses the decline in glucose metabolism—a well-characterized feature of Alzheimer's disease1
Bypass the problem
Taking Axona produces ketone bodies—which the brain can use as an energy source—to manage glucose hypometabolism1,2
Create an alternative energy source
Patients with mild to moderate Alzheimer's disease taking Axona demonstrated improved cognitive function as measured by ADAS-Cog1,2†
Axona
(caprylidene™, USP 6,835,750 and JP 3486778; and patents
pending) is a medical food containing a proprietary formulation
of medium-chain triglycerides (MCTs), specifically caprylic
triglyceride, for the clinical dietary management of the metabolic
processes associated with mild to moderate Alzheimer’s disease.
References:
1. Axona [prescribing information]. Broomfield,
CO: Accera, Inc.; September 2009. 2. Henderson
ST, Vogel JL, Barr LJ, et al. Study of the ketogenic agent AC-1202
in mild to moderate Alzheimer’s disease: a randomized, double-blind,
placebo-controlled, multicenter trial. Nutr Metab (Lond).
2009;6:31.
†ADAS-Cog, Alzheimer’s Disease
Assessment Scale—Cognitive
subscale.
